fezolinetant

Term ID

CHEBI:229236

Synonyms

(4-fluorophenyl)[(8R)-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]methanone
ESN 364
ESN-364
ESN364
fezolinetant
fezolinetantum
Veozah

Definition

A triazolopyrazine that is 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyrazine substituted by 3-methyl-1,2,4-thiadiazol-5-yl, 4-fluorobenzoyl and methyl groups at positions 3, 7, and 8R, respectively. It is a prescription medicine used to reduce moderate to severe vasomotor symptoms due to menopause.

References

cas:1629229-37-3
drugbank:DB15669
kegg.drug:D11976
pmc:PMC9625322
pubmed:31415087
pubmed:33048862
pubmed:33724119
pubmed:34000049
pubmed:34048742
pubmed:36734148
pubmed:36897180
pubmed:36924778
pubmed:37097747
pubmed:37276043
pubmed:37335635
pubmed:37339088
pubmed:37343519
pubmed:37382493
pubmed:37423792
pubmed:37442655
pubmed:37462862
pubmed:37541194
pubmed:37808928
pubmed:37865107
pubmed:37974591
pubmed:38016166
pubmed:38035319
pubmed:38115258
pubmed:38161058
pubmed:38187079
pubmed:38227939
pubmed:38231097
pubmed:38320967
pubmed:38471077
pubmed:38478035
pubmed:38517209
pubmed:38517210
pubmed:38563867
pubmed:38574221
pubmed:38583073
wikipedia.en:Fezolinetant

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from fezolinetant

Phenotype where environments contain fezolinetant

Phenotype modified by environments containing fezolinetant

Phenotype affecting fezolinetant

Human Disease Model